Jiewen R. Fu
Guangxi Key Laboratory Of Marine Drugs
Nanning, 530200, China
Nanning, 530200, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
A novel glycosaminoglycan from the brittlestar Trichaster palmiferus: structure and low-bleed anticoagulant-antithrombotic action.
Journal: Carbohydrate polymers
Published: October 06, 2025
Structure-activity relationship of a potent anti-FXase and antithrombotic chondroitin sulfate-dermatan sulfate hybrid bearing 2,3-O-sulfated motifs from Anthenoides laevigatus.
Journal: Carbohydrate polymers
Published: September 01, 2025
Correction: Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2.
Journal: Molecular biology reports
Published: July 10, 2025
Development of Mathematical Models Using circRNA Combinations (circTulp4, circSlc8a1, and circStrn3) in Mouse Brain Tissue for Postmortem Interval Estimation.
Journal: International journal of molecular sciences
Published: March 11, 2025
Circular RNA circFat3 as a biomarker for construction of postmortem interval Estimation models in mouse brain tissues at multiple temperatures.
Journal: Scientific reports
Published: February 12, 2025
Structural Characterization and Anticoagulant Potential of Colochirus quadrangularis Fucosylated Glycosaminoglycan 5-12 Oligomers with Unusual Branches.
Journal: Marine drugs
Published: January 06, 2025
Exploring the Post Mortem Interval (PMI) Estimation Model by circRNA circRnf169 in Mouse Liver Tissue.
Journal: International journal of molecular sciences
Published: December 28, 2024
Corrigendum: A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers.
Journal: Frontiers in immunology
Published: October 29, 2024
A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers.
Journal: Frontiers in immunology
Published: May 17, 2024
Tripartite motif-containing 28 (TRIM28) expression and cordycepin inhibition in progression, prognosis, and therapeutics of patients with breast invasive carcinoma.
Journal: Journal of Cancer
Published: March 02, 2024
The ENG/VEGFα Pathway Is Likely Affected by a Nonsense Variant of Endoglin (ENG)/CD105, Causing Hereditary Hemorrhagic Telangiectasia Type 1 (HHT1) in a Chinese Family.
Journal: Genes
Published: February 02, 2024
Natural Product Cordycepin (CD) Inhibition for NRP1/CD304 Expression and Possibly SARS-CoV-2 Susceptibility Prevention on Cancers.
Journal: Microorganisms
Published: November 13, 2023
Last Updated: 09/26/2026